News
W.W. Grainger Q2 Earnings Call Highlights
Key Points
- Interested in W.W. Grainger, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Sales increased 10.3%, while daily organic constant-currency growth
Global Industrial Q2 Earnings Call Highlights
Key Points
- Interested in Global Industrial Company? Here are five stocks we like better.
- Revenue growth remained strong: Second-quarter revenue rose 7.7% year over year to $386.6 million, or
Energy Transfer Q2 Earnings Call Highlights
Key Points
- Interested in Energy Transfer LP? Here are five stocks we like better.
- Energy Transfer delivered strong second-quarter results: Adjusted EBITDA rose to approximately $5.1 billion
Emerson Electric Q3 Earnings Call Highlights
Key Points
- Interested in Emerson Electric Co.? Here are five stocks we like better.
- Emerson exceeded expectations in Q3 fiscal 2026, with underlying orders up 7%, sales up 6%, adjusted EPS
EQS-News: BHB Brauholding Bayern-Mitte AG: Halbjahresgeschäft 2026 entwickelt sich im Rahmen der Erwartungen – Prognose für das Gesamtjahr bestätigt
EQS-News: BHB Brauholding Bayern-Mitte AG: Halbjahresgeschäft 2026 entwickelt sich im Rahmen der Erwartungen – Prognose für das Gesamtjahr bestätigt
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 05. August 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 05. August 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Centuri Q2 Earnings Call Highlights
Key Points
- Interested in Centuri Holdings, Inc.? Here are five stocks we like better.
- Record results and raised guidance: Centuri reported second-quarter revenue of $962 million, up 36% on a
Coupang Q2 Earnings Call Highlights
Key Points
- Interested in Coupang, Inc.? Here are five stocks we like better.
- Revenue growth accelerated: Coupang’s Q2 revenue rose 4% year over year to $8.9 billion, or 10% in constant currency
Arista Networks Q2 Earnings Call Highlights
Key Points
- Interested in Arista Networks, Inc.? Here are five stocks we like better.
- Strong growth prompted a higher outlook: Arista’s second-quarter revenue surpassed $3 billion, up 37.7%
Viasat Q1 Earnings Call Highlights
Key Points
- Interested in Viasat Inc.? Here are five stocks we like better.
- Viasat maintained its fiscal 2027 outlook despite first-quarter revenue falling 1% to $1.2 billion and adjusted
Silver Standard Resources Q2 Earnings Call Highlights
Key Points
- Interested in Silver Standard Resources Inc.? Here are five stocks we like better.
- Strong balance sheet and shareholder returns: SSR Mining received approximately $1.5 billion from
SpaceX Q2 Earnings Call Highlights
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX reported strong Q2 growth: Revenue rose 92% year over year to $7.8 billion, while adjusted EBITDA increased 191% to
Rigel Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Rigel Pharmaceuticals, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Rigel reported $78.7 million in revenue and $17.3 million in net income, with
ePlus Q1 Earnings Call Highlights
Key Points
- Interested in ePlus inc.? Here are five stocks we like better.
- Revenue rose modestly, but profitability declined: Fiscal Q1 2027 net sales increased 1% to $649.1 million, while
IperionX Targets 200-Ton Titanium Run Rate as U.S. Supply Chain Takes Shape
Key Points
- Interested in IperionX Limited Sponsored ADR? Here are five stocks we like better.
- IperionX is targeting an annualized titanium production rate of 200 metric tons by year-end at its
The Hackett Group Q2 Earnings Call Highlights
Key Points
- Interested in The Hackett Group, Inc.? Here are five stocks we like better.
- Second-quarter results were mixed: Revenue before reimbursements rose sequentially to $68.3 million, while
Freshworks Q2 Earnings Call Highlights
Key Points
- Interested in Freshworks Inc.? Here are five stocks we like better.
- Freshworks delivered a strong second quarter: Revenue rose 16% year over year to $237.4 million, while the company
Crexendo Q2 Earnings Call Highlights
Key Points
- Interested in Crexendo Inc.? Here are five stocks we like better.
- Strong Q2 growth: Revenue rose 49% year over year to $24.6 million, supported by telecom growth and the ESI
Alphatec Q2 Earnings Call Highlights
Key Points
- Interested in Alphatec Holdings, Inc.? Here are five stocks we like better.
- Q2 revenue rose 15% to $214 million, driven by 20% growth in surgical case volume and a 24% increase in
Arrowhead Pharmaceuticals Q3 Earnings Call Highlights
Key Points
- Interested in Arrowhead Pharmaceuticals, Inc.? Here are five stocks we like better.
- Plozasiran delivered positive Phase III results in severe hypertriglyceridemia, reducing
Astera Labs Q2 Earnings Call Highlights
Key Points
- Interested in Astera Labs, Inc.? Here are five stocks we like better.
- Record results: Astera Labs reported second-quarter revenue of $392.4 million, up 104% year over year, with PCIe
Black Stone Minerals Q2 Earnings Call Highlights
Key Points
- Interested in Black Stone Minerals, L.P.? Here are five stocks we like better.
- Black Stone Minerals raised its quarterly distribution 7% to $0.32 per unit, supported by 1.18x
Aptiv Q2 Earnings Call Highlights
Key Points
- Interested in Aptiv PLC? Here are five stocks we like better.
- Aptiv lowered its full-year outlook after second-quarter revenue rose 2% to $3.3 billion, with weaker China production
Archer Daniels Midland Q2 Earnings Call Highlights
Key Points
- Interested in Archer Daniels Midland Company? Here are five stocks we like better.
- ADM raised its 2026 adjusted EPS outlook to $5.15–$5.60, up from $4.15–$4.70, after reporting